Posters on the topic "Neurooncology self study"

Back
  • eP-NO-A100
A rare case of light chain deposition disease in brain – diagnosis and management in a 34-year-old female
  • Fahd Al Sufiani (Riyadh, SA)
  • eP-NO-A101
Brain metastasis from scalp pleomorphic dermal sarcoma – a rare case report
  • eP-NO-A102
A rare case of a metastatic hepatocellular carcinoma to the pituitary gland
  • eP-NO-A103
Imaging-pathological findings of lesions in the sillar region in a tertiary care center in Mexico
  • eP-NO-A104
Transcriptomic analysis of ZFTA-fusion positive and negative ependymoma reveals significant differential dysregulation of genes related to important signalling pathways – report from a tertiary care centre in North India
  • eP-NO-A105
Anaplastic evolution of pilocytic astrocytomas – a case report and review of the literature
  • eP-NO-A106
High-risk neuroblastoma with recurrence 28 years after initial diagnosis – a case report
  • eP-NO-A107
An unusual spinal tumour with meningeal and histiocytic features – a case report
  • eP-NO-A108
Comparison of clinicopathological differences between the RICH lesions of the brain according to the type of radiation treatment and preceding lesions
  • eP-NO-A110
MGMT gene promoter methylation in diffuse midline glioma, H3K27-mutant
  • eP-NO-A111
Cervical extramedullar intradural intermediate grade melanocytic neoplasm – an aggressive evolution
  • eP-NO-A113
Multiple abnormalities of neurofibromatosis type 2 (meningiomatosis, vestibular schwannomas, at the cervicomedullary junction with syringomyelia-syringobulbia and cortical hamartia) in a previously undiagnosed man – autopsy case report
  • eP-NO-A114
Ganglioneurocytoma of septum pellucidum with prominent dystrophic axonal spheroids
  • eP-NO-A116
A unique case report of adult sellar diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype RTK1 molecular subtype
  • eP-NO-A117
Immunohistochemical expression of H3K27me3 protein in IDH-mutant gliomas
  • eP-NO-A119
Central nervous tissue in ovarian mature teratoma – a histopathological and immunohistochemical study of its neuropathological alterations
  • eP-NO-A120
Next Generation Sequencing (NGS) in glial tumor diagnosis – single center experience
  • eP-NO-A121
Unusual case of Ganglioglioma grade 1 transforming into a IDH mutant high grade astrocytoma to Glioblastoma (IDH wild type) over 10 years
  • eP-NO-A122
Wunderlich syndrome in a woman with Tuberous Sclerosis Complex – autopsy case report
  • eP-NO-A123
Frequent co-occurrence of Alzheimer-type neurodegeneration in glioblastoma-adjacent cortex
  • eP-NO-A124
Different expression and clinical implications of Cancer-Associated Fibroblast (CAF) markers in brain metastases
  • eP-NO-A125
p16 immunohistochemistry as a screening tool for the detection of homozygous CDKN2A deletions in glial tumors and meningiomas
  • eP-NO-A126
Evaluation of 1p deletion by Fluorescence in situ Hybridization in meningiomas – a simple easy to implement prognostic stratifier
  • eP-NO-A127
Chordoid Glioma – a rare tumor of diagnostic dilemma
  • eP-NO-A128
The role of Neutrophil to lymphocyte ratio (NLR) in predicting survival outcome in glioblastoma
  • eP-NO-A129
Meningioma-to-malignant peripheral nerve sheath tumor transdifferentiation by a single genetic event
  • eP-NO-A130
Giant cell enriched IDH wildtype glioblastoma differs in metabolic phenotype, tumor microenvironment composition and DNA methylation age acceleration
  • eP-NO-A131
Application of Spatial Biology to assess prognostic and predictive biomarkers in the tumor microenvironment
  • eP-NO-A132
Molecular and clinical characterization of atypical neurofibromas
  • eP-NO-A133
Rhythmic expression of BMAL in normal human Schwann cells and disturbance of clock gene expression in malignant NF1 associated tumor cells
  • eP-NO-A134
Quantifying heterogenity in WSI using ecological diversity indices is a prognostic marker in Glioblastoma
  • eP-NO-A135
Comprehensive molecular and clinical characterization of glioblatomas with long-term survival
  • eP-NO-A137
Scaffold-based (MatrigelTM) 3D culture technique of glioblastoma recovers a patient-like immunosuppressive phenotype
  • eP-NO-A138
The role of p16 immunohistochemistry as a prognostic biomarker in meningiomas
  • eP-NO-A139
Mapping the tumor microenvironment in primary and recurrent glioblastoma by multiplex immunofluorescence, methylation and AI-based approaches
  • eP-NO-A73
Glioma diagnosis in the genomic era – gene panel NGS as a key tool
  • eP-NO-A76
Uncovering a novel population of proliferative cells defined by the expression of BCAS1 in glioblastoma
  • eP-NO-A78
Machine learning-based assessment of intratumor heterogeneity in glioblastoma
  • eP-NO-A79
A rare case of a primary intracranial sarcoma associated with a DICER1 mutation with focal cartilaginous differentiation
  • eP-NO-A80
Study of inherited mismatch repair deficiency in pediatric and adult gliomas
  • eP-NO-A82
Implementation of the fifth edition of the WHO classification of tumors of the central nervous system and its implications in a Belgian cohort
  • eP-NO-A83
Molecular characterization of precursor lesions of High Grade Astrocytoma with Piloid Features (HGAP)
  • eP-NO-A84
Quantitative characterization of the cell composition in recurrent glioblastoma and its impact on survival
  • eP-NO-A85
Distribution and tumor cell proximity of immune cells in the tumor core, transition zone and periphery of glioblastomas
  • eP-NO-A87
Rosette-forming glioneuronal tumors may exhibit H3 K28me3 loss along with H3 K27M mutation
  • eP-NO-A88
Epigenetic and genetic characterization of T-cell lymphomas
  • eP-NO-A89
Atypical teratoid/rhabdoid tumour (AT/RT) in an adolescent
  • eP-NO-A90
The epigenetic effect of Dexamethasone on glioblastoma cell line
  • eP-NO-A91
Sarcoidosis lymphoma syndrome presenting as primary central nervous system lymphoma developed during long-term immunosuppressive treatment – a case report
  • eP-NO-A92
DNA methylation-based classification of pituitary carcinomas
  • eP-NO-A93
The epigenetic therapeutic effect of Juglone on glioblastoma
  • eP-NO-A94
Clinicopathological features of rosette-forming glioneuronal tumour – single centre experience
  • eP-NO-A95
Microglia and macrophages in human glioblastomas and relations to tumour growth
  • eP-NO-A96
POST (Preview Of Spinal Tumours) study
  • eP-NO-A97
Can we predict glioblastoma, IDH wild type with FGFR3::TACC3 fusion morphologically?
  • eP-NO-A98
Cribriform neuroepithelial tumor with intracytoplasmic eosinophilic hyaline droplets in an infant
  • eP-NO-A99
Papillary tumors of the skull base – are they all corticotroph adenomas?
  • PS1-NO-A49
The correlation between pleomorphic xanthoastrocytoma methylation class and the integrated pathological diagnosis
  • PS1-NO-A50
Insights into molecular biology of Pleomorphic Xanthoastrocytoma
  • PS1-NO-A51
Polymorphous low-grade neuroepithelial tumor of the young – a short series from a tertiary care centre in South India
  • PS1-NO-A52
Diffuse gliomas with low-grade histopathological features and FGFR3-TACC3 fusion – a diagnostic dilemma
  • PS1-NO-A53
VGLL-altered CNS schwannoma is a new tumor entity with distinct DNA-methylation profile and recurrent gene fusions of either VGLL3 or VGLL1
  • PS1-NO-A54
Chordoid glioma – a case report of an intracranial mass in a forty-four year old female
  • PS1-NO-A55
Characterisation of gene fusions in MYB(L1)-altered gliomas
  • PS1-NO-A56
Molecular characteristics and prognostic biomarkers of central neurocytoma
  • PS2-NO-A41
Utility of DNA-methylation profiling and Integrated Molecular-Morphologic Meningioma classification as a prognostic biomarker in CNS WHO grade 2 meningiomas – a retrospective feasibility study in a patient cohort with resected meningiomas in New Zealand
  • PS2-NO-A42
Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas
  • PS2-NO-A43
Using molecular and immunohistochemical features to predict outcomes in grade 3 meningiomas
  • PS2-NO-A45
Transcription factor expression profile in immunonegative pituitary adenomas
  • PS2-NO-A46
Lineage-dependent expression of Islet-1 in pituitary neuroendocrine tumors
  • PS2-NO-A47
Expression of transcription factors is associated with higher recurrence in craniopharyngiomas
  • PS2-NO-A48
Expression of apolipoproteins in adamantinomatous craniopharyngiomas correlates with tumor recurrence and survival
  • PS6-NO-A57
A novel definition of low-grade astrocytoma IDH-mutant to inform observational follow-up and the upcoming era of IDH mutant inhibitors
  • PS6-NO-A58
Beyond IDH1 R132H mutation – clinicopathological characteristics of non-canonical IDH mutant gliomas
  • PS6-NO-A59
Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma
  • PS6-NO-A60
Comprehensive genomic profiling of ATRX-deficient IDH-wildtype adult high-grade gliomas reveals clinically relevant genetic patterns
  • PS6-NO-A61
Gliomas with immunohistochemical loss of MMR proteins – clinico-pathological evaluation, a tertiary care cancer institute experience
  • PS6-NO-A62
Proteome signatures are closely associated with histomorphology in Embryonal Tumors with Multilayered Rosettes (ETMR)
  • PS6-NO-A63
Adult medulloblastoma – clinico-molecular spectrum, an institutional experience
  • PS6-NO-A64
DNA methylation profiling of adult spinal glial tumours – results from a large single centre study
  • PS7-NO-A65
Leveraging attention-based convolutional neural networks for meningioma classification in computational histopathology
  • PS7-NO-A66
Morphology-based molecular classification of spinal cord ependymomas using deep neural networks
  • PS7-NO-A67
A deep learning-approach to infer somatic alterations in glioma using digital tissue slides
  • PS7-NO-A68
brAIn App – a versatile smartphone app to annotate histopathological images for enhanced AI training and medical education
  • PS7-NO-A69
Crowd powered neuropathology annotations for machine learning algorithms – a Citizen Science pilot study focused on the Hispanic community
  • PS7-NO-A70
Rapid DNA methylation-based classification of pediatric brain tumours from ultrasonic aspirate specimens
  • PS7-NO-A71
Outsourcing of molecular testing for CNS tumors in the era of integrated molecular diagnosis – an experience from King Hussein Cancer Center
  • PS7-NO-A72
Comparing p16 and MTAP loss of expression in detecting CDKN2A homozygous deletion in pleomorphic xanthoastrocytoma
  • S14-NO-A36
Mean global DNA methylation serves as independent prognostic marker in glioblastoma, IDH wildtype
  • S14-NO-A37
Exploring Myeloid-Lymphoid interactions in Glioblastomas – NK cells as rheostats in the immune microenvironment
  • S14-NO-A38
Newly designed fish MYCN/ID2 is useful to identify paediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype
  • S14-NO-A39
Fatal outcome of a case of central neurocytoma – a rare and challenging diagnosis
  • S14-NO-A40
DICER-1 mutant primary intracranial sarcoma – a call for extensive molecular profiling in CNS tumours with spindle morphology
  • S14-OT-A327
Conumee 2.0 – enhanced copy-number variation analysis from DNA methylation arrays for humans and mice
  • S14-OT-A328
Detection of structural DNA variations in pediatric brain tumors using optical genome mapping
    • v1.27.1
    • © Conventus Congressmanagement & Marketing GmbH